BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 3140080)

  • 1. Is analgesic nephropathy still a problem in Belgium?
    Elseviers MM; De Broe ME
    Nephrol Dial Transplant; 1988; 3(2):143-9. PubMed ID: 3140080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analgesic nephropathy in Belgium is related to the sales of particular analgesic mixtures.
    Elseviers MM; De Broe ME
    Nephrol Dial Transplant; 1994; 9(1):41-6. PubMed ID: 8177475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of diagnostic criteria for analgesic nephropathy in patients with end-stage renal failure: results of the ANNE study. Analgesic Nephropathy Network of Europe.
    Elseviers MM; Waller I; Nenoy D; Levora J; Matousovic K; Tanquerel T; Pommer W; Schwarz A; Keller E; Thieler H
    Nephrol Dial Transplant; 1995; 10(6):808-14. PubMed ID: 7566608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The analgesic problem in the Federal Republic of Germany: analgesic consumption, frequency of analgesic nephropathy and regional differences.
    Pommer W; Glaeske G; Molzahn M
    Clin Nephrol; 1986 Dec; 26(6):273-8. PubMed ID: 3802594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of legislative measures on the sales of analgesics and the subsequent prevalence of analgesic nephropathy: a comparative study in France, Sweden and Belgium.
    Noels LM; Elseviers MM; de Broe ME
    Nephrol Dial Transplant; 1995; 10(2):167-74. PubMed ID: 7753450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prevention of analgetics nephropathy].
    Elseviers MM; De Broe ME
    Arch Belg; 1989; 47(1-4):77-80. PubMed ID: 2610578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic criteria of analgesic nephropathy in patients with end-stage renal failure: results of the Belgian study.
    Elseviers MM; Bosteels V; Cambier P; De Paepe M; Godon JP; Lins R; Lornoy W; Matthys E; Moeremans C; Roose R
    Nephrol Dial Transplant; 1992; 7(6):479-86. PubMed ID: 1320226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analgesic nephropathy: an important cause of chronic renal failure.
    Cove-Smith JR; Knapp MS
    Q J Med; 1978 Jan; 47(185):49-69. PubMed ID: 674550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiology of analgesic nephropathy in Belgium.
    Vanherweghem JL; Even-Adin D
    Clin Nephrol; 1982 Mar; 17(3):129-33. PubMed ID: 7067174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nephropathy as a hazard of analgesic abuse.
    Anandan JV; Matzke GR
    Am J Hosp Pharm; 1981 Oct; 38(10):1536-9. PubMed ID: 7294057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Analgesic nephropathy].
    Pintér I; Nagy J
    Orv Hetil; 1998 Nov; 139(47):2839-43. PubMed ID: 9846064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone disease in analgesic nephropathy.
    Fassett RG; Lien JW; McClure J; Mathew TH
    Clin Nephrol; 1982 Dec; 18(6):273-9. PubMed ID: 7151345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. End-stage renal failure due to analgesic nephropathy, its changing pattern and cardiovascular mortality. EDTA-ERA Registry Committee.
    Brunner FP; Selwood NH
    Nephrol Dial Transplant; 1994; 9(10):1371-6. PubMed ID: 7816247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Epidemiological studies of the frequency of the abuse of analgesics].
    Mohr T; Küster G; de Vries JX; Waldherr R; Walter-Sack J; Rieser PF; Ritz E
    Dtsch Med Wochenschr; 1990 Jan; 115(4):129-32. PubMed ID: 2298128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analgesic nephropathy in Hungary: the HANS study.
    Pintér I; Mátyus J; Czégány Z; Harsányi J; Homoki M; Kassai M; Kiss E; Kiss I; Ladányi E; Locsey L; Major L; Misz M; Nagy L; Polner K; Rédl J; Solt I; Tichy B; Török M; Varga G; Wagner G; Wórum I; Zsoldos B; Pótó L; Dérczy K; Wittmann I; Nagy J
    Nephrol Dial Transplant; 2004 Apr; 19(4):840-3. PubMed ID: 15031338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of withdrawal of phenacetin-containing analgesics on the incidence of kidney and urothelial cancer and renal failure.
    McCredie M; Stewart JH; Mathew TH; Disney AP; Ford JM
    Clin Nephrol; 1989 Jan; 31(1):35-9. PubMed ID: 2783667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Phenacetin abuse II. Chronic renal insufficiency in Basle autopsies].
    Mihatsch MJ; Schmidlin P; Brunner FP; Hofer HO; Six P; Zollinger HU
    Schweiz Med Wochenschr; 1980 Jan; 110(4):116-24. PubMed ID: 6987731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Characteristics of terminal analgesics-induced nephropathy].
    Schwarz A; Pommer W; Kühn-Freitag G; Keller F; Molzahn M; Offermann G
    Schweiz Med Wochenschr; 1985 Jun; 115(23):790-5. PubMed ID: 3875149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Obituary to analgesic nephropathy--an autopsy study.
    Mihatsch MJ; Khanlari B; Brunner FP
    Nephrol Dial Transplant; 2006 Nov; 21(11):3139-45. PubMed ID: 16891638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is analgesic nephropathy a problem in the south-west region of Poland?
    Franek E; Kokot F; Grzeszczak W; Gajos L
    Nephron; 1996; 72(2):353. PubMed ID: 8684568
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.